The Lancet Microbe in conversation with

Claas Kirchhelle and Lloyd Czaplewski on AMR governance and financing

The Lancet Group

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 36:44

Elena Dalla Vecchia talks with Claas Kirchhelle and Lloyd Czaplewski about the current antimicrobial resistance (AMR) governance (with a historical perspective on how it came to be), the 2015 WHO Global Action Plan (GAP) on AMR and the draft for the 2026 updated GAP, the role of social sciences in addressing AMR, the financing mechanisms in antibiotic research and development (including push and pull incentives with public and philantropic funding), and perspectives on the future of the fight against AMR. 

Click here to read the full article:

https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00243-5/fulltext
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00216-2/fulltext

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv